Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

Webinar On DeNovo Classification Process

24 November 2014, Mississauga, Canada


Introduction
This webinar provides information on FDA’s DeNovo classification process. The webinar explains how a device classified as a Class III device but has the risk level of a Class I or II device may be downclassified to its correct risk classification. The webinar will cover when the DeNovo process may be used, information contained in a DeNovo request, the 2 DeNovo pathways and FDA review process for DeNovo.

This is a must attend session for those personnel that require an understanding of the FDA’s DeNovo Classification process.

Areas Covered in the Session :
FDA DeNovo Classification Process
Request for DeNovo application
2 DeNovo Pathways
FDA DeNovo Review Process
Interactive Q&A Session

Who Will Benefit:
Regulatory Affairs Personnel
Quality Personnel
Clinical Personnel
Research Personnel
Laboratory Personnel
Manufacturing Personnel
Legal Personnel
Clinical Research Associates
Personnel who require a general understanding of the FDA’s DeNovo Classification Process

Price Tags:
Live
Single Live : For One Participant
$ 249
Corporate Live : For Max. 10 Participants
$ 899
Recording
Single REC : For One Participant - Unlimited Access for 6 Months
$ 299

For more information and enquiries contact us at
Compliance Trainings
5939 Candle brook Ct, Mississauga, ON L5V 2V5, Canada
Customer Support: 416-915-4458
Email: support@compliancetrainings.com
Speakers
Venue
Compliance Trainings

Compliance Trainings, 5939 Candlebrook Ct, Mississauga, L5V 2V5, Canada

Organised by
Compliance Trainings
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*